Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/28324

Title:	Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study.
Authors:	D'Agostino, Maria-Antonietta Wakefield, Richard J Berner-Hammer, Hilde Vittecoq, Olivier Filippou, Georgios Balint, Peter Möller, Ingrid Iagnocco, Annamaria Naredo, Esperanza Østergaard, Mikkel Boers, Maarten Gaillez, Corine Van Holder, Karina Le Bars, Manuela View more
Keywords:	DMARDs (biologic) Disease Activity Rheumatoid Arthritis Ultrasonography View more
Mesh:	Abatacept Adult Aged Antirheumatic Agents Arthritis, Rheumatoid Biomarkers Drug Therapy, Combination Europe Female Humans Joints Male Methotrexate Middle Aged Predictive Value of Tests Prospective Studies Severity of Illness Index Synovitis Treatment Outcome Ultrasonography, Doppler View more
Issue Date:	Oct-2016
Citation:	Ann. Rheum. Dis..2016 Oct;(75)10:1763-9
Abstract:	To study the responsiveness of a combined power Doppler and greyscale ultrasound (PDUS) score for assessing synovitis in biologic-naïve patients with rheumatoid arthritis (RA) starting abatacept plus methotrexate (MTX).
PMID:	26590174
URI:	https://hdl.handle.net/20.500.12530/28324
Rights:	openAccess
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. General U. Gregorio Marañón > Artículos

Files in This Item:

File	Description	Size	Format
PMC5036216.pdf		612.29 kB	Adobe PDF	View/Open